Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle Table of Contents Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle FDA Launches Investigation …
Pharma
-
-
Indonesian Finance Minister Sri Mulyani Expects Improved Expense Management and Business Continuity Table of Contents Indonesian Finance Minister Sri Mulyani Expects Improved Expense Management and Business Continuity Focus on Proportional …
-
“`html Servier Acquires rights to Darovasertib for Uveal melanoma Treatment Servier Expands Oncology Portfolio with Darovasertib Acquisition Table of Contents Servier Expands Oncology Portfolio with Darovasertib Acquisition Understanding Uveal Melanoma …
-
Procurement Opportunity: Essential Medications for Udaipur Healthcare A tender has been released for the supply of critical pharmaceutical products to support healthcare services in Udaipur. This represents a meaningful opportunity …
-
The GLP-1 Revolution: A New Era in Diabetes and Weight Management The rise of GLP-1 medications has sent ripples through the healthcare landscape, promising a new era in the management …
-
Health
Circle Pharma Presents Promising Preclinical Data on First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor CID-078 at the San Antonio Breast Cancer Symposium 2024
Circle Pharma Presents Preclinical Data on CID-078 for Triple Negative Breast Cancer at SABCS 2024 South San Francisco, CA (December 9, 2024) – Circle Pharma, a clinical-stage biopharmaceutical company focused …